Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Indian Science
  4. Volume 1, Issue 1
  5. Article
Volume 1, Issue 1
  • ISSN: 2210-299X
  • E-ISSN: 2210-3007
file format text download EPUB
file format pdf download PDF
side by side viewer icon HTML

Abstract

Arthritis is one of the major inflammatory diseases and is a global issue. Arthritis is currently an utmost public health problem and it severely affects impact the life of the geriatric population. There are several types of arthritis such as Rheumatoid arthritis, Osteoarthritis, Gout, and Fibromyalgia, which limit the mobility of the patient. In most cases, the reason for the disease is not known clearly and available treatment can reduce the symptoms but cannot cure it completely. Though Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), glucocorticoids, and Disease Modifying Anti Rheumatic Drugs (DMARDs) are the first-line treatments available in arthritis, gastrointestinal discomfort, low solubility, strong first-pass metabolism, low bioavailability, and systemic adverse reactions are the main drawbacks related to these drugs when used in long-term. Based on the evidence related to side effects of the current treatment methodology, several recent studies and developments have been designed and summarized in this field. From these studies, it has been observed that the transdermal drug delivery system can minimize the side effects associated with the oral dosage forms and can deliver the drug directly to the target site along with controlled and prolonged drug release. Hence, novel approaches in transdermal drug delivery systems like transdermal patches and microneedle therapy could be an alternative approach in the treatment and management of arthritis.

© 2023 The Author(s). Published by Bentham Science Publisher.
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/cis/10.2174/012210299X276015231102052904
2023-01-01
2025-01-28

  • From This Site

    /content/journals/cis/10.2174/012210299X276015231102052904
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/cis/1/1/CIS-1-E2210299X276015.html?itemId=/content/journals/cis/10.2174/012210299X276015231102052904&mimeType=html&fmt=ahah

References

  1. MohantyS. PandaS. BhanjaA. PalA. ChandraS.S. Novel drug delivery systems for rheumatoid arthritis: an approach to better patient compliance.Biomed. Pharmacol. J.201912115717010.13005/bpj/1624
     [Google Scholar]
  2. HunterD.J. FelsonD.T. Osteoarthritis.BMJ2006332754263964210.1136/bmj.332.7542.63916543327
     [Google Scholar]
  3. Arthritis Health EducationAvailable from:https://www.arthritis.org/about-arthritis
  4. SenthelalS. Arthritis.StatPearls https://www.ncbi.nlm.nih.gov/books/ NBK518992/
    [Google Scholar]
  5. WangJ. ZengJ. LiuZ. ZhouQ. WangX. ZhaoF. ZhangY. WangJ. LiuM. DuR. Promising strategies for transdermal delivery of arthritis drugs: Microneedle systems.Pharmaceutics2022148173610.3390/pharmaceutics1408173636015362
     [Google Scholar]
  6. RosetiL. DesandoG. CavalloC. PetrettaM. GrigoloB. Articular cartilage regeneration in osteoarthritis.Cells2019811130510.3390/cells811130531652798
     [Google Scholar]
  7. BullockJ. RizviS.A.A. SalehA.M. AhmedS.S. DoD.P. AnsariR.A. AhmedJ. Rheumatoid arthritis: A brief overview of the treatment.Med. Princ. Pract.201827650150710.1159/00049339030173215
     [Google Scholar]
  8. Treatments for OsteoarthritisAvailable from:https://www.arthritis.org/health-wellness/treatment/treatment-plan/disease-management/treatments-for-osteoarthritis
  9. Your RA is in Remission! Now What?Available from:https://www.arthritis.org/health-wellness/treatment/treatment-plan/disease-management/your-ra-is-in-remission!-now-what
  10. RaduA.F. BungauS.G. Management of rheumatoid arthritis: An overview.Cells20211011285710.3390/cells1011285734831081
     [Google Scholar]
  11. GaffoA. SaagK.G. CurtisJ.R. Treatment of rheumatoid arthritis.Am. J. Health Syst. Pharm.200663242451246510.2146/ajhp05051417158693
     [Google Scholar]
  12. D’ArcyY. MantyhP. YakshT. DonevanS. HallJ. SadrarhamiM. ViktrupL. Treating osteoarthritis pain: Mechanisms of action of acetaminophen, nonsteroidal anti-inflammatory drugs, opioids, and nerve growth factor antibodies.Postgrad. Med.2021133887989410.1080/00325481.2021.194919934252357
     [Google Scholar]
  13. KiddB.L. LangfordR.M. WodehouseT. Arthritis and pain. Current approaches in the treatment of arthritic pain.Arthritis Res. Ther.20079321410.1186/ar214717572915
     [Google Scholar]
  14. GulR. JahanF. NaseerF. Emerging role of chondroitin sulfate based nanocarriers in improving the therapeutic outcome of NSAIDs in the treatment of osteoarthritis through the TDDDS.J. Shifa Tameer-e-Millat Univ.202141556510.32593/jstmu/Vol4.Iss1.133
     [Google Scholar]
  15. JeongW.Y. KwonM. ChoiH.E. KimK.S. Recent advances in transdermal drug delivery systems: a review.Biomater. Res.20212512410.1186/s40824‑021‑00226‑634321111
     [Google Scholar]
  16. JainN.K. Controlled and Novel Drug Delivery.CBS Publishers &Distributors Pvt Limited2019
     [Google Scholar]
  17. AkhtarN. SinghV. YusufM. KhanR. A. Non-invasive drug delivery technology: Development and current status of transdermal drug delivery devices, techniques and biomedical applications.Biomed. Eng.202065324327210.1515/bmt‑2019‑0019
     [Google Scholar]
  18. ChellathuraiM.S. LingV.W. PalanirajanV. Fabrication and evaluation of transdermal microneedles for a recombinant human keratinocyte growth factor.Turk. J. Pharmaceut. Sci.20211819610310.4274/tjps.galenos.2020.2103333634684
     [Google Scholar]
  19. JungJ.H. JinS.G. Microneedle for transdermal drug delivery: current trends and fabrication.J. Pharm. Investig.202151550351710.1007/s40005‑021‑00512‑433686358
     [Google Scholar]
  20. ZhaoW. ZhengL. YangJ. MaZ. TaoX. WangQ. Dissolving microneedle patch-assisted transdermal delivery of methotrexate improve the therapeutic efficacy of rheumatoid arthritis.Drug Deliv.202330112113210.1080/10717544.2022.215751836533887
     [Google Scholar]
  21. ShuZ. CaoY. TaoY. LiangX. WangF. LiZ. LiZ. GuiS. Polyvinylpyrrolidone microneedles for localized delivery of sinomenine hydrochloride: preparation, release behavior of in vitro & in vivo, and penetration mechanism.Drug Deliv.202027164265110.1080/10717544.2020.175452432329377
     [Google Scholar]
  22. TekkoI.A. ChenG. Domínguez-RoblesJ. ThakurR.R.S. HamdanI.M.N. VoraL. LarrañetaE. McElnayJ.C. McCarthyH.O. RooneyM. DonnellyR.F. Development and characterisation of novel poly (vinyl alcohol)/poly (vinyl pyrrolidone)-based hydrogel-forming microneedle arrays for enhanced and sustained transdermal delivery of methotrexate.Int. J. Pharm.202058611958010.1016/j.ijpharm.2020.11958032593650
     [Google Scholar]
  23. LiuC. GuanY. TianQ. ShiX. FangL. Transdermal enhancement strategy of ketoprofen and teriflunomide: The effect of enhanced drug-drug intermolecular interaction by permeation enhancer on drug release of compound transdermal patch.Int. J. Pharm.201957211880010.1016/j.ijpharm.2019.11880031678378
     [Google Scholar]
  24. KandilL.S. HanafyA.S. AbdelhadyS.A. Galantamine transdermal patch shows higher tolerability over oral galantamine in rheumatoid arthritis rat model.Drug Dev. Ind. Pharm.20204661910.1080/03639045.2020.176402532378971
     [Google Scholar]
  25. KhanD. QindeelM. AhmedN. KhanA.U. KhanS. RehmanA. Development of novel pH-sensitive nanoparticle-based transdermal patch for management of rheumatoid arthritis.Nanomedicine202015660362410.2217/nnm‑2019‑038532098563
     [Google Scholar]
  26. HuangD. SunM. BuY. LuoF. LinC. LinZ. WengZ. YangF. WuD. Microcapsule-embedded hydrogel patches for ultrasound responsive and enhanced transdermal delivery of diclofenac sodium.J. Mater. Chem. B Mater. Biol. Med.20197142330233710.1039/C8TB02928H32254681
     [Google Scholar]
  27. SongH. WenJ. LiH. MengY. ZhangY. ZhangN. ZhengW. Enhanced transdermal permeability and drug deposition of rheumatoid arthritis via sinomenine hydrochloride-loaded antioxidant surface transethosome.Int. J. Nanomedicine2019143177318810.2147/IJN.S18884231118630
     [Google Scholar]
  28. PatelA. SolankiR. JainS. DangiY. S. DubeyN. Formulation, development and evaluation of etoricoxib containing transdermal patches in arthritis management.IJRAR201854242249
     [Google Scholar]
  29. VandanaK.R. YalavarthiP. SundaresanC.R. SriramaneniR. VadlamudiH. In-vitro assessment and pharmacodynamics of nimesulide incorporated Aloe vera transemulgel.Curr. Drug Discov. Technol.201411216216710.2174/157016381066613120223372124295369
     [Google Scholar]
  30. PrausnitzM.R. LangerR. Transdermal drug delivery.Nat. Biotechnol.200826111261126810.1038/nbt.150418997767
     [Google Scholar]
/content/journals/cis/10.2174/012210299X276015231102052904
Loading
A Comprehensive Review on Management and Treatment of Arthritis Specially Emphasizing Treatment with Transdermal Patch
Curr. Indian Sci. 1, E2210299X276015 (2023); https://doi.org/10.2174/012210299X276015231102052904
/content/journals/cis/10.2174/012210299X276015231102052904
/content/journals/cis/10.2174/012210299X276015231102052904
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): DMARDs; Microneedle; Osteoarthritis (OA); Rheumatoid arthritis (RA); Transdermal drug delivery system (TDDS); Transdermal patch

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test